OBJECTIVE: To compare the incidence of cancer among women with and without a history of pre-eclampsia. DESIGN: Cohort study. SETTING: Jerusalem perinatal study of women who delivered in three large hospitals in West Jerusalem during 1964-76. PARTICIPANTS: 37 033 women. MAIN OUTCOME MEASURES: Age adjusted and multivariable adjusted hazard ratios for cancer incidence for the entire cohort and for women who were primiparous at study entry. RESULTS: Cancer developed in 91 women who had pre-eclampsia and 2204 who did not (hazard ratio 1.27, 95% confidence interval 1.03 to 1.57). The risk of site specific cancers was increased, particularly of the stomach, ovary epithelium, breast, and lung or larynx. The incidence of cancer of the stomach, breast, ovary, kidney, and lung or larynx was increased in primiparous women at study entry who had a history pre-eclampsia. CONCLUSIONS: A history of pre-eclampsia is associated with increases in overall risk of cancer and incidence at several sites. This may be explained by environmental and genetic factors common to the development of pre-eclampsia and cancer in this population.
OBJECTIVE: To compare the incidence of cancer among women with and without a history of pre-eclampsia. DESIGN: Cohort study. SETTING: Jerusalem perinatal study of women who delivered in three large hospitals in West Jerusalem during 1964-76. PARTICIPANTS: 37 033 women. MAIN OUTCOME MEASURES: Age adjusted and multivariable adjusted hazard ratios for cancer incidence for the entire cohort and for women who were primiparous at study entry. RESULTS:Cancer developed in 91 women who had pre-eclampsia and 2204 who did not (hazard ratio 1.27, 95% confidence interval 1.03 to 1.57). The risk of site specific cancers was increased, particularly of the stomach, ovary epithelium, breast, and lung or larynx. The incidence of cancer of the stomach, breast, ovary, kidney, and lung or larynx was increased in primiparous women at study entry who had a history pre-eclampsia. CONCLUSIONS: A history of pre-eclampsia is associated with increases in overall risk of cancer and incidence at several sites. This may be explained by environmental and genetic factors common to the development of pre-eclampsia and cancer in this population.
Authors: R Troisi; H A Weiss; R N Hoover; N Potischman; C A Swanson; D R Brogan; R J Coates; M D Gammon; K E Malone; J R Daling; L A Brinton Journal: Epidemiology Date: 1998-11 Impact factor: 4.822
Authors: Rebecca Troisi; Nancy Potischman; James M Roberts; Roberta Ness; William Crombleholme; David Lykins; Pentti Siiteri; Robert N Hoover Journal: Int J Epidemiol Date: 2003-06 Impact factor: 7.196
Authors: Susan Harlap; A Michael Davies; Lisa Deutsch; Ronit Calderon-Margalit; Orly Manor; Ora Paltiel; Efrat Tiram; Rivka Yanetz; Mary C Perrin; Mary B Terry; Dolores Malaspina; Yechiel Friedlander Journal: Paediatr Perinat Epidemiol Date: 2007-05 Impact factor: 3.980
Authors: Zahna Bigham; Yvonne Robles; Karen M Freund; Julie R Palmer; Kimberly A Bertrand Journal: Breast Cancer Res Treat Date: 2022-04-28 Impact factor: 4.624
Authors: Huiyan Ma; Katherine D Henderson; Jane Sullivan-Halley; Lei Duan; Sarah F Marshall; Giske Ursin; Pamela L Horn-Ross; Joan Largent; Dennis M Deapen; James V Lacey; Leslie Bernstein Journal: Breast Cancer Res Date: 2010-06-18 Impact factor: 6.466
Authors: Theodore M Brasky; Yanli Li; David J Jaworowicz; Nancy Potischman; Christine B Ambrosone; Alan D Hutson; Jing Nie; Peter G Shields; Maurizio Trevisan; Carole B Rudra; Stephen B Edge; Jo L Freudenheim Journal: Cancer Causes Control Date: 2013-06-05 Impact factor: 2.506